LES & Co SRL
LES & Co reported total assets of 820,248 € at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Aug 2026).
The score of LES & Co shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +691 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
LES & Co's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 91,305 € | ||||
| Equity | 144,948 € | ||||
| Cash | 221,638 € | ||||
| EBITDA | 176,009 € | ||||
| Total assets | 820,248 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Aug 2026
- Year ended 31 Dec 2024filed on 26 Aug 2025
- Year ended 31 Dec 2023filed on 26 Jul 2024
- Year ended 31 Dec 2022filed on 26 Jul 2023
- Year ended 31 Dec 2021filed on 21 Jul 2022
LES & Co's financial analysis
- Solvency17.7%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of LES & Co
LES & Co's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0896.061.947
- VAT number
- BE0896061947
- Peppol
- Registered · 0208:0896061947 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Feb 2008
- Registered office
- 8750 Wingene
- Latest accounts
- 2025 · filed on 27 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
LES & Co (SRL) has been based in Wingene since 2008, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 91,305 € and equity of 144,948 €; its revenue is not published. Its solvency stands at 17.7%, below the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to LES & Co
Companies in the same business, of comparable size and area, outside its group.
- Alex Eneman Wholesale of pharmaceutical and medical goods Wingene · balance sheet 674,757 €
- Christiaens Dental Instruments Wholesale of pharmaceutical and medical goods Waregem · balance sheet 649,128 €
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
- Vet Shops Wholesale of pharmaceutical and medical goods Lummen · balance sheet 826,731 €
- Launchpad Europe Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet 120,635 €
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Biocon Biologics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.09m
- Wimeq Wholesale of pharmaceutical and medical goods Heusden-Zolder · balance sheet 48,978 €
Frequently asked questions about LES & Co
What is the revenue of LES & Co?
LES & Co files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of LES & Co?
In Belgium, the VAT number is the company number prefixed with BE: BE0896061947 for LES & Co, if the company is VAT-registered. Its company number (CBE) is 0896.061.947.
Where is the registered office of LES & Co?
According to the CBE register, the registered office of LES & Co is in 8750 Wingene.
What is the equity of LES & Co?
At the close of the 2025 financial year, the equity of LES & Co amounts to 144,948 €, a solvency of 17.7% of total assets.
Who manages LES & Co?
The register lists 2 active mandates at LES & Co. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of LES & Co
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →